-
Mollerup Clausen posted an update 6 months, 3 weeks ago
Lapatinib (LAP) is an anticancer drug generally used to treat breast and lung cancer. It exhibits hypersensitivity reactions in addition to dermatological adverse effects and photosensitivity. Moreover, LAP binds to serum proteins and is readily biotransformed in humans, giving rise to several metabolites, such as N- and O-dealkylated products…[Read more]
-
Mollerup Clausen became a registered member 7 months ago
Skip to content
